Patent details

EP3102214 Title: COMPOSITION FOR VECTORIZING AN ANTI-CANCER AGENT

Basic Information

Publication number:
EP3102214
PCT Application Number:
EP2015052527
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157042805
PCT Publication Number:
WO2015118113
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
COMPOSITION FOR VECTORIZING AN ANTI-CANCER AGENT
French Title of Invention:
COMPOSITION DESTINÉE À VECTORISER UN AGENT ANTICANCÉREUX
German Title of Invention:
ZUSAMMENSETZUNG ZUR VEKTORISIERUNG EINES ANTIKREBSMITTELS
SPC Number:

Dates

Filing date:
06/02/2015
Grant date:
13/04/2022
EP Publication Date:
14/12/2016
PCT Publication Date:
13/08/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/04/2022
EP B1 Publication Date:
13/04/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/02/2023
Expiration date:
06/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/04/2022
 
 

Name:
Guerbet
Address:
15 Rue des Vanesses, 93420 Villepinte, France (FR)

Inventor

1

Name:
ROBIC, Caroline
Address:
France (FR)

2

Name:
MAYER, Jean-François
Address:
France (FR)

Priority

Priority Number:
1450972
Priority Date:
07/02/2014
Priority Country:
France (FR)

Classification

IPC classification:
A61K 31/704; A61K 9/00; A61K 47/14; A61K 9/107; A61K 47/44; A61P 35/00; A61K 49/00; A61K 51/12;

Publication

European Patent Bulletin

Issue number:
202215
Publication date:
13/04/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages